The Future of Intra Nasal : Affordable Nano Technology Applications
21st July 2022 | Synergia Forum : 131
RA MashelkarFormer Director General of the Council of Scientific and Industrial Research
Chas BountraPro Vice Chancellor Innovation, University of Oxford
Intranasal: The way forward
The rationale of nasal administration of drugs is threefold : It bypasses the first-pass metabolism as compared to drugs administered orally ; and secondlyensures higher bioavailability. Thirdly, the transportation of drug molecules from nasal epithelium to the brain bypassing the blood-brain-barrier ensures lower doses of drug. Synergia Biosciences has developed an affordable nano-emulsion platform for enhanced targeted drug delivery to the Central Nervous System. The platform has a 20 years grant patent from the US, Japan, Europe and India. The platform has been devloped through supply chain engineering , a novel model for drug development . Supply chain engineering has been widely used for innovation and creating some of the most valuable companies in strategic industries like aerospace and defence , information technology , tele communication etc..